✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹13,850 Cr.
P/E
36.08
  • Indegene
  • Syngene Internation.
  • Jubilant Pharmova
FAQs on Indegene Ltd. Shareprice

There is not enough historical data for the companies share price.

Indegene is not expensive.
Latest PE of Indegene is 36.08, while 3 year average PE is 42.3.
Also latest EV/EBITDA of Indegene is 25.31 while 3yr average is 29.44.

Growth Table
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova
Balance Sheet
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova
Cash Flow
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova
Quarterly Results
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Indegene Ltd. Financials

Balance sheet of Indegene is strong.
It shouldn't have solvency or liquidity issues.

The debt of Indegene is decreasing.
Latest debt of Indegene is -₹549.7 Crs as of Sep-24.
This is less than Mar-24 when it was ₹21.1 Crs.

Yes, profit is increasing.
The profit of Indegene is ₹384 Crs for TTM, ₹337 Crs for Mar 2024 and ₹266 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Indegene latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech